Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors

Published:2018-07-02 Issue:1 Volume:60 Page:200-207
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Erbilgin Yucel¹^ORCID,Eskazan Ahmet Emre²^ORCID,Hatirnaz Ng Ozden¹,Salihoglu Ayse²,Elverdi Tugrul²,Firtina Sinem¹,Tasar Orcun¹,Mercan Sevcan¹,Sisko Sinem¹,Khodzhaev Khusan¹,Ongoren Seniz²,Ar Muhlis Cem²,Baslar Zafer²,Soysal Teoman²,Sayitoglu Muge¹^ORCID,Ozbek Ugur¹³

Affiliation:

1. Aziz Sancar Institute of Experimental Medicine Department of Genetics, Istanbul University, Istanbul, Turkey;

2. Division of Haematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey;

3. Department of Medical Genetics, School of Medicine, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey

Funder

Istanbul University

Turkish Society of Hematology

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1473573

Reference41 articles.

1. Epidemiology of chronic myeloid leukaemia (CML)

2. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

3. Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr–Abl mutations and mutational analysis

4. Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy

5. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of a novel NGS based BCR::ABL1 kinase domain mutation detection assay in Indian cohort;Scientific Reports;2024-07-08

2. A Retrospective Analysis of BCR-ABL-1 Kinase Domain Mutations in Frontline TKI Resistant Chronic Myeloid Leukemia Patients: A Single Centre Experience;Indian Journal of Hematology and Blood Transfusion;2024-04-23

3. Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study;BMC Research Notes;2024-04-20

4. Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-02

5. Chronic myeloid leukemia kinase domain mutations: A retrospective descriptive study on the therapeutic and prognostic significance in patients at King Edward VIII Hospital, KwaZulu‐Natal, South Africa;Health Science Reports;2023-06-30